Letter to the shareholdersWe are very pleased to announce that we late yesterday received the permission from MHRA (UK health authorities) to start the CE mark human trial, read more
We are very pleased to announce that we late yesterday received the permission from MHRA (UK health authorities) to start the CE mark human trial, read more
